[go: up one dir, main page]

FI942803L - Ipsapirone medicinal product - Google Patents

Ipsapirone medicinal product Download PDF

Info

Publication number
FI942803L
FI942803L FI942803A FI942803A FI942803L FI 942803 L FI942803 L FI 942803L FI 942803 A FI942803 A FI 942803A FI 942803 A FI942803 A FI 942803A FI 942803 L FI942803 L FI 942803L
Authority
FI
Finland
Prior art keywords
ipsapirone
medicinal product
medicinal
product
ipsapirone medicinal
Prior art date
Application number
FI942803A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI942803A7 (en
FI942803A0 (en
Inventor
Peter Serno
Wolfgang Fischer
Roland Rupp
Mark Versavel
Ulrich Tenter
Gerhard Schmidt
Guenter Schoellnhammer
Maria Ammen
Shinji Maegata
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI942803A0 publication Critical patent/FI942803A0/en
Publication of FI942803A7 publication Critical patent/FI942803A7/en
Publication of FI942803L publication Critical patent/FI942803L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI942803A 1993-06-15 1994-06-13 Ipsapirone medicinal product FI942803L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4319760A DE4319760A1 (en) 1993-06-15 1993-06-15 Ipsapiron drug preparation

Publications (3)

Publication Number Publication Date
FI942803A0 FI942803A0 (en) 1994-06-13
FI942803A7 FI942803A7 (en) 1994-12-16
FI942803L true FI942803L (en) 1994-12-16

Family

ID=6490360

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942803A FI942803L (en) 1993-06-15 1994-06-13 Ipsapirone medicinal product

Country Status (16)

Country Link
EP (1) EP0629402A1 (en)
JP (1) JPH06345649A (en)
KR (1) KR950000150A (en)
CN (1) CN1099263A (en)
AU (1) AU6345794A (en)
CA (1) CA2125620A1 (en)
CZ (1) CZ146494A3 (en)
DE (1) DE4319760A1 (en)
FI (1) FI942803L (en)
HU (1) HUT70759A (en)
IL (1) IL109993A0 (en)
NO (1) NO942228L (en)
NZ (1) NZ260732A (en)
PL (1) PL303822A1 (en)
SK (1) SK72494A3 (en)
ZA (1) ZA944187B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
DK1140105T3 (en) * 1998-12-24 2004-02-23 Janssen Pharmaceutica Nv Controlled release galantamine preparation
WO2004103338A1 (en) * 2003-05-19 2004-12-02 Bioprogress Plc Adhesives and film modifying compositions
HUE066812T2 (en) * 2020-09-02 2024-09-28 Beijing Biostar Pharmaceuticals Co Ltd Solid oral formulation of utidelone

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE79029T1 (en) * 1989-02-11 1992-08-15 Bayer Ag CONTROLLED-RELEASE PHARMACEUTICALS.
DD297767A5 (en) * 1990-03-06 1992-01-23 Bayer Aktiengesellschaft,De MEDICINAL PRODUCTS WITH CONTROLLED ACTIVE INGREDIENTS
JPH04360826A (en) * 1991-06-07 1992-12-14 Bayer Yakuhin Kk Controlled release pharmaceutical preparation

Also Published As

Publication number Publication date
NO942228L (en) 1994-12-16
NZ260732A (en) 1996-02-27
CN1099263A (en) 1995-03-01
HUT70759A (en) 1995-10-30
IL109993A0 (en) 1994-10-07
PL303822A1 (en) 1995-01-09
FI942803A7 (en) 1994-12-16
ZA944187B (en) 1995-02-08
AU6345794A (en) 1994-12-22
KR950000150A (en) 1995-01-03
EP0629402A1 (en) 1994-12-21
NO942228D0 (en) 1994-06-14
HU9401771D0 (en) 1994-09-28
CZ146494A3 (en) 1995-01-18
JPH06345649A (en) 1994-12-20
FI942803A0 (en) 1994-06-13
CA2125620A1 (en) 1994-12-16
SK72494A3 (en) 1995-04-12
DE4319760A1 (en) 1994-12-22

Similar Documents

Publication Publication Date Title
FI954402L (en) New pharmaceutical product
FI962094A7 (en) Corneal products
FI956338A7 (en) Absorbent products
FI951098L (en) Pharmaceutical packaging
ITRM920237A1 (en) IMPROVED USE OF BRONCODILATORY MEDICINAL PRODUCTS B2.
FI921060L (en) PHARMACEUTICAL AEROSOL FORMULERINGAR
FI930882A0 (en) PHARMACEUTICAL FORM
NO923127L (en) PHARMACEUTICAL COMBINATION FORM
FI924456L (en) MEDICINE
FI931251A0 (en) PHARMACEUTICAL FORM
DK86492D0 (en) PHARMACEUTICAL PRODUCT
DE69219279D1 (en) Skin cleanser
NO961589D0 (en) Pharmaceutical mixtures
FI941881L (en) Hot-returnable product
FI942803A7 (en) Ipsapirone medicinal product
FI920761L (en) MINERALLY PRODUCT
FI962040L (en) Disposable absorbent product
FI921786A7 (en) PHARMACEUTICAL ASSOCIATION
FI921785A7 (en) PHARMACEUTICAL ASSOCIATION
UA25976C2 (en) ANTI-ULTRASONIC MEDICINAL PRODUCT
DK128993D0 (en) PHARMACEUTICAL PRODUCT / -PLANTE
SE9203298D0 (en) ANTIDOPAMINE EFFECT MEDICINAL PRODUCT
DK137192D0 (en) PHARMACEUTICAL PRODUCT / -PLANTE
ATE160286T1 (en) ORAL CARE PRODUCTS
SE9102577D0 (en) ANTIDOPAMINE EFFECT MEDICINAL PRODUCT